Regulatory Updates

The association will hold a mandatory 8‑hour pharmacist training on Sep 19 at Gangdong Kyung Hee University Hospital for pharmacists who have not met the annual requirement.

Huons N’s Chuncheon facility expands output to 16,500 t/yr and obtains Process Safety Management approval, enabling larger-scale contract manufacturing of functional ingredients.

Pharmacist groups have held relay rallies for 350 days, urging the government to define licensing duties and tighten drug‑handling rules.

The Health and Welfare Committee’s bill review subcommittee is expected to meet in mid‑month to consider pending pharmacist‑related legislation, including amendments to the pharmacist law.

Onnuri clarified that Mega Onnuri pharmacies operate under an independent pharmacist franchise model, detailing the head office’s role and sub‑lease structure after regional societies raised concerns.

South Korea's Ministry of Health and Welfare creates a new office to integrate regional, essential and public healthcare, with its first director pledging collaborative action to close medical gaps.

Korea's Ministry of Health and Welfare unveils a designation system granting generic price incentives to semi‑innovative pharma companies that meet R&D investment thresholds, excluding violations older than five years.

The Health Care Organizations Union criticizes the government's decision to set next year's health insurance national support at 14.4%, calling it an insult to workers and low‑income citizens.

The Guro‑gu Pharmacy Association delivered local pharmacists’ concerns to the National Assembly, warning that a full rollout of remote prescription delivery could impact community pharmacy networks and patient safety.

A National Assembly Budget Office study finds health receives 16.2% of total tax spending in 2024, the third‑largest share after social welfare and industry.

The Korean government has begun discussing nationwide drug delivery for telemedicine patients, prompting pharmacists and civil society to organize a protest in Seoul.

The Gwangju Pharmaceutical Association, together with Gyeonggi and Gangwon societies, seeks additional review of Onnuri H&C’s response on the Mega Onnuri Pharmacy, citing concerns over fairness, impact and sub‑lease structures.